TP53 and cancer: It has been shown that CARF activates p53, a key tumor suppressor in a ARF-dependent and independent manners15,16 leading to execution of growth arrest and pre-mature senescence, as marked by p21WAF1 activation in human cancer and normal cells, respectively17,18.